BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30010013)

  • 1. Roles of microRNA in prostate cancer cell metabolism.
    Kasomva K; Sen A; Paulraj MG; Sailo S; Raphael V; Puro KU; Assumi SR; Ignacimuthu S
    Int J Biochem Cell Biol; 2018 Sep; 102():109-116. PubMed ID: 30010013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA in prostate cancer.
    Khanmi K; Ignacimuthu S; Paulraj MG
    Clin Chim Acta; 2015 Dec; 451(Pt B):154-60. PubMed ID: 26415820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of microRNA on cancer cell metabolism.
    Chen B; Li H; Zeng X; Yang P; Liu X; Zhao X; Liang S
    J Transl Med; 2012 Nov; 10():228. PubMed ID: 23164426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.
    Fuse M; Kojima S; Enokida H; Chiyomaru T; Yoshino H; Nohata N; Kinoshita T; Sakamoto S; Naya Y; Nakagawa M; Ichikawa T; Seki N
    J Hum Genet; 2012 Nov; 57(11):691-9. PubMed ID: 22854542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activin A regulates microRNAs and gene expression in LNCaP cells.
    Ottley EC; Nicholson HD; Gold EJ
    Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-372 Suppresses Migration and Invasion by Targeting p65 in Human Prostate Cancer Cells.
    Kong X; Qian X; Duan L; Liu H; Zhu Y; Qi J
    DNA Cell Biol; 2016 Dec; 35(12):828-835. PubMed ID: 27673408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of microRNA dysregulation in the development of prostate cancer.
    Massillo C; Dalton GN; Farré PL; De Luca P; De Siervi A
    Reproduction; 2017 Oct; 154(4):R81-R97. PubMed ID: 28878093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-Related Tumor Acidosis Affects MicroRNA Expression Pattern in Prostate and Breast Tumor Cells.
    Riemann A; Reime S; Thews O
    Adv Exp Med Biol; 2017; 977():119-124. PubMed ID: 28685435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.
    Hagman Z; Larne O; Edsjö A; Bjartell A; Ehrnström RA; Ulmert D; Lilja H; Ceder Y
    Int J Cancer; 2010 Dec; 127(12):2768-76. PubMed ID: 21351256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-613 represses prostate cancer cell proliferation and invasion through targeting Frizzled7.
    Ren W; Li C; Duan W; Du S; Yang F; Zhou J; Xing J
    Biochem Biophys Res Commun; 2016 Jan; 469(3):633-8. PubMed ID: 26703210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of EZH2 in aerobic glycolysis of prostate cancer through miR-181b/HK2 axis.
    Tao T; Chen M; Jiang R; Guan H; Huang Y; Su H; Hu Q; Han X; Xiao J
    Oncol Rep; 2017 Mar; 37(3):1430-1436. PubMed ID: 28184935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells.
    Mao Y; Chen H; Lin Y; Xu X; Hu Z; Zhu Y; Wu J; Xu X; Zheng X; Xie L
    Oncol Rep; 2013 Jul; 30(1):327-33. PubMed ID: 23670210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-1297 inhibits prostate cancer cell proliferation and invasion by targeting the AEG-1/Wnt signaling pathway.
    Liang X; Li H; Fu D; Chong T; Wang Z; Li Z
    Biochem Biophys Res Commun; 2016 Nov; 480(2):208-214. PubMed ID: 27746178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs and epithelial-mesenchymal transition in prostate cancer.
    Sekhon K; Bucay N; Majid S; Dahiya R; Saini S
    Oncotarget; 2016 Oct; 7(41):67597-67611. PubMed ID: 27588490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1.
    Rajendiran S; Parwani AV; Hare RJ; Dasgupta S; Roby RK; Vishwanatha JK
    Mol Cancer; 2014 Nov; 13():250. PubMed ID: 25406943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-103 suppresses tumor cell proliferation by targeting PDCD10 in prostate cancer.
    Fu X; Zhang W; Su Y; Lu L; Wang D; Wang H
    Prostate; 2016 May; 76(6):543-51. PubMed ID: 26771762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of MicroRNAs as Key Players in Cancer Cell Metabolism.
    Subramaniam S; Jeet V; Clements JA; Gunter JH; Batra J
    Clin Chem; 2019 Sep; 65(9):1090-1101. PubMed ID: 31101638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells.
    Erdmann K; Kaulke K; Rieger C; Salomo K; Wirth MP; Fuessel S
    J Cancer Res Clin Oncol; 2016 Nov; 142(11):2249-61. PubMed ID: 27562865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The miRNA-kallikrein axis of interaction: a new dimension in the pathogenesis of prostate cancer.
    White NM; Youssef YM; Fendler A; Stephan C; Jung K; Yousef GM
    Biol Chem; 2012 Apr; 393(5):379-89. PubMed ID: 22505520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting MicroRNAs in Prostate Cancer Radiotherapy.
    Ni J; Bucci J; Chang L; Malouf D; Graham P; Li Y
    Theranostics; 2017; 7(13):3243-3259. PubMed ID: 28900507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.